$CTIC Recent Headlines Insider filings one way to track

New Post Public Reply Private Reply Replies (0) Message Board

Jun 5, 2014 at 12:52 PM

$CTIC Recent Headlines

Insider filings one way to track tricky micro-cap biotechs 12:14 p.m. Oct. 24, 2012 - blogs.marketwatch.com
Friday’s biggest gaining and declining stocks 4:27 p.m. Oct. 5, 2012 - Greg Morcroft
Cell Therapeutics down 21% in premarket 7:15 a.m. Oct. 5, 2012 - Steve Gelsi
Tuesday’s biggest gaining and declining stocks 4:53 p.m. Oct. 2, 2012 - MarketWatch
Cell Therapeutics up 21% in premarket 8:38 a.m. Oct. 2, 2012 - Steve Gelsi
CTIC gets orphan drug status for brain cancer drug 7:37 a.m. Oct. 2, 2012 - MarketWatch.com
Cell Therapeutics: progress with lymphoma Drug 6:59 a.m. Sept. 24, 2012 - MarketWatch.com
Tuesday’s top gaining and declining stocks 4:57 p.m. Sept. 11, 2012 - MarketWatch
Cell Therapeutics soars 24% on EU drug launch 10:12 a.m. Sept. 11, 2012 - Val Brickates Kennedy
Tuesday’s biggest gaining and declining stocks 5:01 p.m. Sept. 4, 2012 - Greg Morcroft
Updates, advisories and surprises 5:01 p.m. July 31, 2012 - MarketWatch
Cell Therapeutics announces stock placement 11:45 a.m. July 31, 2012 - Val Brickates Kennedy
Friday’s biggest gaining and declining stocks 5:21 p.m. Feb. 17, 2012 - Kate Gibson
Monday’s biggest gaining and declining stocks 5:49 p.m. Jan. 30, 2012 - Kate Gibson
Cell Therapeutics pulls application; shares slump 2:25 p.m. Jan. 30, 2012 - MarketWatch.com
Stocks to watch Monday: Blue Coat, Cooper 5:35 p.m. Dec. 9, 2011 - William Spain
Friday’s biggest gaining & declining stocks 5:35 p.m. Dec. 9, 2011 - Kate Gibson
Thursday’s biggest gaining & declining stocks 4:59 p.m. June 30, 2011 - Kate Gibson
Cell Therapeutics tumbles over offerings 9:09 a.m. June 30, 2011 - MarketWatch.com

Name change for Cell Therapeutics 7:12 a.m. May 30, 2014 - Seeking Alpha
Thirteen Analyst Stocks Under $10 With Big Upside Calls 8:23 a.m. May 24, 2014 - 247WallSt.com
Why Cell Therapeutics (CTIC) Stock Is Spiking Today 12:27 p.m. May 22, 2014 - TheStreet.com
Interesting CTIC Put And Call Options For July 19th 10:51 a.m. May 20, 2014 - TheStreet.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
Cell Therapeutics: Enticing To All, Convincing To None 9:10 a.m. May 7, 2014 - Seeking Alpha
Cell Therapeutics CEO Discusses Q1 2014 Results - Earnings Call Transcript 10:52 p.m. April 29, 2014 - Seeking Alpha
10-Q: CELL THERAPEUTICS INC 5:10 p.m. April 29, 2014 - Edgar Online - (EDG = 10Q, 10K)
Furiex Pharmaceuticals (FURX) Surges: Stock Moves 28.6% Higher - Tale of the Tape 9:21 a.m. April 29, 2014 - Zacks.com
Pacira Pharmaceuticals (PCRX) Soars: Stock Adds 11.4% in Session - Tale of the Tape 9:21 a.m. April 10, 2014 - Zacks.com
Zacks Rank #1 Additions for Friday - Tale of the Tape 9:30 a.m. March 28, 2014 - Zacks.com
Cell Therapeutics: 5 Different Insiders Have Sold Shares This Month 10:39 a.m. March 24, 2014 - Seeking Alpha
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc. ... 10:12 a.m. March 24, 2014 - GuruFocus.com
Is It Too Late to Buy the Rally in Small Caps? 1:00 a.m. March 7, 2014 - InvestorPlace.com
Cell Therapeutics' CEO Discusses Q4 2013 Results - Earnings Call Transcript 10:21 p.m. March 4, 2014 - Seeking Alpha
10-K: CELL THERAPEUTICS INC 6:32 p.m. March 4, 2014 - Edgar Online - (EDG = 10Q, 10K)
Cell Therapeutics Q4 revenue soars due to Baxter license payment 5:49 p.m. March 4, 2014 - Seeking Alpha
Cell Therapeutics' Pixuvri gets final NICE recommendation 10:47 a.m. Feb. 27, 2014 - Seeking Alpha
TetraLogic Pharmaceuticsls And The Chatter About A Cure For Cancer 6:18 p.m. Jan. 31, 2014 - Seeking Alpha
Is The Healthcare Sector Pulling Back Or Crashing? 6:40 a.m. Jan. 28, 2014 - Seeking Alpha

Cell Therapeutics, Inc. Announces Change of Name to CTI BioPharma Corp. 1:30 a.m. May 30, 2014 - PR Newswire - PRF
SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Cell Therapeutics, Inc. Regarding Possible Breaches of Fiduciary Duty 12:52 p.m. May 29, 2014 - PR Newswire - PRF
CollabRx's Mobile App Simplifies Cancer Treatment Options 10:46 a.m. May 29, 2014 - ACCESSWIRE
Cell Therapeutics to Present at the Jefferies 2014 Global Healthcare Conference 1:30 a.m. May 29, 2014 - PR Newswire - PRF
Top Gainers on the Move -- Research on Aeropostale, FirstEnergy, Cell Therapeutics, and Dyax 5:00 a.m. May 28, 2014 - PR Newswire - PRF
Technical Coverage on Biotech Stocks -- Research on Celgene, Cell Therapeutics, Geron, and BioMarin Pharma 9:15 a.m. May 6, 2014 - PR Newswire - PRF
Cell Therapeutics Reports First Quarter 2014 Financial Results 4:01 p.m. April 29, 2014 - PR Newswire - PRF
PIXUVRI® Launched In UK For Adult Patients With Multiply Relapsed Or Refractory Aggressive B-Cell Non-Hodgkin Lymphoma 1:30 a.m. April 29, 2014 - PR Newswire - PRF
Cell Therapeutics to Report First Quarter 2014 Financial Results on April 29, 2014 1:30 a.m. April 22, 2014 - PR Newswire - PRF
Insider Trading Research -- Alerts for Ariad Pharmaceuticals, Cell Therapeutics, Staples, Sirius XM, Facebook, and Bank of America 8:55 a.m. March 25, 2014 - PR Newswire - PRF
Initiation of Clinical Trials, Completed Acquisitions, Financial Results, and Earnings Release Schedules - Analyst Notes on Cell Therapeutics, Intrexon, Chimerix, Receptos, and Revance Therapeutics 8:00 a.m. March 18, 2014 - PR Newswire - PRF
Investor-Edge.com Most Active Equities Watch List: Cell Therapeutics, Yandex, Himax Technologies, and CytRx 8:54 a.m. March 14, 2014 - PR Newswire - PRF
Cell Therapeutics to Present at the 26th Annual ROTH Conference 2:30 a.m. March 5, 2014 - PR Newswire - PRF
Cell Therapeutics Reports Fourth Quarter and Full Year 2013 Financial Results 5:00 p.m. March 4, 2014 - PR Newswire - PRF
CTI Opens Enrollment for PERSIST-2 Phase 3 Trial of Pacritinib for Patients with Myelofibrosis Who Have Low Platelet Counts 2:30 a.m. March 3, 2014 - PR Newswire - PRF
NICE Publishes Final Guidance on PIXUVRI® (pixantrone) 2:30 a.m. Feb. 27, 2014 - PR Newswire - PRF
Cell Therapeutics to Report Fourth Quarter and Full Year 2013 Financial Results on March 4, 2014 2:30 a.m. Feb. 25, 2014 - PR Newswire - PRF
Hercules Offshore Losses Decrease from $121 million to $27 million 10:17 a.m. Feb. 24, 2014 - ACCESSWIRE
Glu Mobile and Siri XM Stock Volume Soars on Fourth-Quarter Results: Glu Mobile Inc.'s (NASDAQ: GLUU), Sirius XM Holdings Inc. (NASDAQ: SIRI), Zynga Inc. (NASDAQ:ZNGA, Cell Therapeutics Inc. (NASDAQ:CTIC) 11:12 a.m. Feb. 11, 2014 - ACCESSWIRE
Cell Therapeutics Appoints Karen Ignagni to Board of Directors 2:30 a.m. Feb. 3, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

GELITA Showcases Collagen Innovations at SupplySide 2026

Collagen Solutions Front and Center First up, a little chat about collagen might be in order. For folks not tied into the science side, it sounds like a trendy wellness potion. But here comes GELITA at SupplySide Global 2026, showing it's the real McCoy. Nestled in Booth #4565, they're laying out a spread of next-gen collagen innovations aimed at everything from wound...

AEVEX Facing Class Action: Deadline Looms for Investors

The Clock is Ticking for AVEX Investors News flash, folks: If you bought into AEVEX Corp. (NYSE: AVEX) between mid-April and early June this year, you might have a legal gold mine on your hands—or at least a shot to join a class action that could knock some dollars back into your pocket. Mark it on your calendar—October 20, 2026, is the last call to toss your hat in...

New Chapter Recovery Garners Key Accreditations

Accreditations That Matter It's not every day a treatment facility pops its head up with credentials that weigh like a ton of bricks. New Chapter Recovery in New Jersey just snagged two heavy hitters: Joint Commission accreditation and LegitScript certification. These badges don’t just glimmer for show; they’re the market's assurance against empty promises—an...

TomoIQ Unveils Money Finder at Money20/20 Event

Breaking Down Financial Barriers with AI In the hustle of Money20/20 USA in Las Vegas, TomoIQ dropped a financial bombshell with their latest tool, Money Finder. This isn't just another app in the sea of fintech solutions. Nope, this one promises to cut through the complexities that most folks face when trying to get their financial house in order. An AI Buddy for...

AEVEX Faces 48-Hour Deadline for Investor Class Action

Clock Ticking on AEVEX Lawsuit Participation Ah, the twists and turns of the stock market! AEVEX Corp. (NYSE: AVEX) finds itself knee-deep in a class action lawsuit, and investors have a mere 48 hours left to make their stand as the lead plaintiff. This legal saga stems from the company's April 2026 IPO and spills into the muddy waters of securities law violations....

Kansai Medical Ushers in New Era of Cancer Research

Breaking Ground in Cancer Treatment Trials I've seen some thrilling breakthroughs in my time following the pharmaceutical industry, but what Kansai Medical University and Daiichi Sankyo are doing elevates the game. They're rolling out the first patient dose of DS1025 in Osaka, Japan—a move that marks the onset of a global Phase 1 clinical trial. This is no ordinary...

AI-Designed Antivirals: A Brave New World

Pushing the Boundaries with AI in Drug Discovery It seems some smart folks over in South Korea are giving the pharma game a fresh twist, pitting artificial intelligence against viral invaders in a newfangled brawl. Professors from Korea University have managed to blend AI's computing prowess with good ol' lab doggedness to sniff out potential antiviral compounds. The...

UEG's New Advisory Board: Elevating Patient Voices

Breaking Ground with Patient Representation Today's not-so-sunny forecast from Barcelona wasn't about the weather. United European Gastroenterology (UEG) rolled out its shiny new Patient Representatives Advisory Board (PRAB) during UEG Week 2026. This isn't just another committee on a never-ending list—it's a serious platform aimed at turning patient murmurs into a...

2GenPen & LordCap Team Up: Game-Changer in ABS?

New Kids on the Structured Credit Block? Well, it looks like we're in for a ride with 2GenPen teaming up with Lord Capital to shake up the asset-backed securities (ABS) world. They're strutting their stuff by launching a strategic collaboration to boost credit analysis. Think of it as a power-up for ABS transactions—because nobody loves a murky credit rating. The Heart...

Dickinson Brands Celebrates Witch Hazel Legacy with Event

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...